CAH

Cardinal Health
D

CAH

Arincen75/100B

Cardinal Health operating income 1986–2027

Cardinal Health's operating income in Q1 FY2027, the three months to 30 September 2026, was 753.00M USD, up 12.7% on the same quarter a year before. Cardinal Health's operating income over the last twelve months was 2.70B USD, up 13.6% on the twelve months before. In fiscal year 2026 it was 2.61B USD, up 14.9% on the year before.

Last updated 7 Nov 2026 · Next report 4 Feb 2027

Operating income

Operating income · +0.6% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 20262.70B+13.60%1.05%10.05B3.90%3.58B
FY202630 Jun 20262.61B+14.86%1.03%9.77B3.84%3.48B
FY202530 Jun 20252.28B+83.02%1.02%8.17B3.67%3.11B
FY202430 Jun 20241.24B+65.29%0.55%7.41B3.27%1.96B
FY202330 Jun 2023752.00M—0.37%6.89B3.36%1.44B
FY202230 Jun 2022-607.00M-228.60%-0.33%6.48B3.58%55.00M
FY202130 Jun 2021472.00M—0.29%6.78B4.17%1.29B
FY202030 Jun 2020-4.10B-298.93%-2.68%6.87B4.49%-2.62B
FY201930 Jun 20192.06B+1,534.92%1.42%6.83B4.70%3.05B
FY201830 Jun 2018126.00M-94.06%0.09%7.18B5.25%1.13B
FY201730 Jun 20172.12B-13.79%1.63%6.54B5.03%2.84B
FY201630 Jun 20162.46B+13.79%2.02%6.54B5.38%3.10B
FY201530 Jun 20152.16B+14.64%2.11%5.71B5.57%2.56B
FY201430 Jun 20141.89B+89.26%2.07%5.16B5.67%2.39B
FY201330 Jun 2013996.00M-44.42%0.99%4.92B4.87%1.41B
FY201230 Jun 20121.79B+18.36%1.67%4.54B4.22%2.12B
FY201130 Jun 20111.51B+15.84%1.48%4.16B4.05%1.92B
FY201030 Jun 20101.31B+1.52%1.33%3.78B3.84%1.58B
FY200930 Jun 20091.29B-7.54%1.34%5.53B5.76%1.64B
FY200830 Jun 20081.39B+1.36%1.59%5.63B6.45%1.66B
FY200730 Jun 20071.37B-25.54%1.58%5.25B6.04%1.84B
FY200630 Jun 20061.84B+3.52%2.32%5.28B6.63%2.22B
FY200530 Jun 20051.78B-23.53%2.45%5.01B6.89%2.21B
FY200430 Jun 20042.33B+6.57%3.61%4.74B7.35%2.70B
FY200330 Jun 20032.19B+19.26%3.86%4.51B7.95%2.59B
FY200230 Jun 20021.83B+23.31%3.59%4.05B7.91%2.21B
FY200130 Jun 20011.49B+16.13%3.10%3.61B7.53%1.77B
FY200030 Jun 20001.28B+22.88%3.34%3.13B8.17%1.54B
FY199930 Jun 19991.04B+21.44%4.15%2.82B11.24%1.28B
FY199830 Jun 1998858.10M+19.90%4.07%1.11B5.25%1.08B
FY199730 Jun 1997715.70M+143.60%3.89%956.20M5.20%924.80M
FY199630 Jun 1996293.80M+14.86%3.18%747.80M8.09%333.30M
FY199530 Jun 1995255.80M+197.44%3.07%485.70M5.82%285.30M
FY199430 Jun 199486.00M+45.76%1.49%372.20M6.43%103.00M
FY199330 Jun 199359.00M+24.47%3.00%134.00M6.81%66.20M
FY199230 Jun 199247.40M+36.60%2.88%115.50M7.01%53.00M
FY199130 Jun 199134.70M+39.92%2.93%87.10M7.35%39.30M
FY199030 Jun 199024.80M+36.26%2.84%63.30M7.24%27.90M
FY198931 Mar 198918.20M+40.00%2.60%50.30M7.18%21.00M
FY198831 Mar 198813.00M+4.84%2.48%37.20M7.09%15.00M
FY198731 Mar 198712.40M+47.62%1.90%50.20M7.70%16.00M
FY198631 Mar 19868.40M—1.96%32.60M7.60%10.40M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Cardinal Health's operating income

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.